Trials / Completed
CompletedNCT06303219
Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome
Comparative Effects of Traditional Moderate Intensity Training and High Intensity Interval Training on Anxiety, Fatigue and Quality of Life in Polycystic Ovarian Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Riphah International University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
To determine the comparative effects of traditional moderate intensity training and high intensity interval training on Anxiety, fatigue and Quality of Life in females with polycystic ovarian syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RADITIONAL MODERATE INTENSITY TRAINING | It consists of patients who will receive High-intensity interval training, including running as well as walking at 80% to 95% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks. The total duration of this session will be 50 minutes |
| OTHER | HIGH INTENSITY INTERVAL TRAINING | It consists of patients who will receive Moderate-intensity interval training, including running as well as walking at 60% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks. The total duration of this session will be 50 minutes ( |
Timeline
- Start date
- 2023-11-23
- Primary completion
- 2024-08-01
- Completion
- 2024-08-19
- First posted
- 2024-03-12
- Last updated
- 2024-09-04
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06303219. Inclusion in this directory is not an endorsement.